Evidence map›Paper›PMID 24084692›Full record

ArticleRNA biology2013

miR-25 and miR-92a regulate insulin I biosynthesis in rats.

Dwi Setyowati Karolina, Sugunavathi Sepramaniam, Hui Zhing Tan, Arunmozhiarasi Armugam, Kandiah Jeyaseelan

Open access · bronzeAbstract read
In one paragraph

Article in RNA biology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 57 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Downregulation ofJournal of clinical medicine research · 2024
    Article
  5. PTBP1 as a potential regulator of disease.Molecular and cellular biochemistry · 2024
    Review
  6. Review
  7. Article
  8. Human pancreatic islet microRNAs implicated in diabetes and related traits by large-scale genetic analysis.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. MicroRNAs, Parkinson's Disease, and Diabetes Mellitus.International journal of molecular sciences · 2021
    Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 4 countries.

Dwi Setyowati KarolinaDepartment of Biochemistry; Yong Loo Lin School of Medicine; National University Health System; Singapore.
Sugunavathi Sepramaniam
Hui Zhing Tan
Arunmozhiarasi Armugam
Kandiah Jeyaseelan
Yong In University · KRUniversity Health System · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The 3' UTR of insulin has been identified as a critical region that confers mRNA stability, which is crucial for promoting transcription in response to glucose challenge. miRNAs are endogenously encoded non-coding RNAs that function as regulators of gene expression. This regulatory function is generally mediated by complementary binding to the 3'UTR of its mRNA targets that affects subsequent translational process. Genes involved in the regulation of glucose homeostasis, particularly in insulin production, have been found as targets of several miRNAs. Yet, no direct miRNA-based regulators of insulin biosynthesis have been identified. In this study, identification of possible miRNA-based regulators of insulin production is explored. Members of a miRNA family, miR-25 and miR-92a, are found as direct modulators of insulin expression. Overexpression of miR-25 or miR-92a reduced insulin expression while inhibition of miR-25 and miR-92a expression using corresponding antagomiRs promoted insulin expression and ultimately enhanced glucose-induced insulin secretion. Furthermore, suppression of insulin secretion by pre miR-9 could be attenuated by treatment with anti-miR-25 or miR-92a. Interestingly, we found the binding site of miR-25 and miR-92a to overlap with that of PTBP1, an important RNA binding molecule that stabilizes insulin mRNA for translation. Despite the increase in PTBP1 protein in the pancreas of diabetic rats, we observed insulin expression to be reduced alongside upregulation of miR-25 and miR-92a, suggesting an intricate regulation of insulin (bio)synthesis at its mRNA level.

Indexed as

3' Untranslated RegionsAnimalsBase SequenceBinding SitesDiabetes Mellitus, Type 2Disease Models, AnimalGene Expression RegulationHeterogeneous-Nuclear RibonucleoproteinsInsulinMicroRNAsMolecular Sequence DataPancreasPolypyrimidine Tract-Binding ProteinRatsRats, WistarRNA, Messenger3' Untranslated RegionsHeterogeneous-Nuclear RibonucleoproteinsInsulinMicroRNAsPolypyrimidine Tract-Binding ProteinPtbp1 protein, ratRNA, Messenger3′ untranslated regiongene regulationhyperglycemiainsulin biosynthesismicroRNAs

Identifiers

PMID24084692
PMCPMC3817158
OpenAlexW2079095924

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.